← Leaderboards
Daniel W Rosenberg
University Of Connecticut Storrs
$10,048,813
Attributed
$11,611,193
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $954K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,611,193 · 11
By mechanism
R01$10,320,537 · 5
R21$838,480 · 2
R03$305,459 · 2
P20$146,144 · 1
M01$573 · 1
Top collaborators
- Christian Jobin3 shared
- George M Weinstock2 shared
Others in their field
Top investigators on “Lesion”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$112,011,044
- Ronald T Mitsuyasu · University Of California Los Angeles$100,903,367
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,218,842
- John Anthony Baron · Dartmouth College$46,892,408
- C Kent Osborne · Baylor College Of Medicine$45,919,490
Research focus
LesionColonAdenomaPathway InteractionsTumorMucous MembraneColorectal CancerMalignant NeoplasmsGrowthColon CarcinomaCancer RiskResponseMolecularImageMouse ModelSignal TransductionHigh RiskAberrant Crypt FociGenesCellsCancer PreventionInterestBaseColon Carcinogenesis
Grant awards (39)
Microbiota, Metabolites, and Colon Neoplasia$575,313
R01 · FY2025 · CA · contact PI
Microbiota, Metabolites, and Colon Neoplasia$557,628
R01 · FY2024 · CA · contact PI
Microbiota, Metabolites, and Colon Neoplasia$631,851
R01 · FY2023 · CA · contact PI
Microbiota, Metabolites, and Colon Neoplasia$649,547
R01 · FY2022 · CA · contact PI
(PQ1) Mechanisms for Early Onset Colorectal Cancer$186,468
R21 · FY2022 · CA · contact PI
Microbiota, Metabolites, and Colon Neoplasia$710,422
R01 · FY2021 · CA · contact PI
(PQ1) Mechanisms for Early Onset Colorectal Cancer$243,568
R21 · FY2021 · CA · contact PI
Cell specific blockade of PGE2 formation in the colon$82,000
R03 · FY2020 · CA · contact PI
(PQ11) Dietary strategies to enhance FOLFOX cancer therapies$218,700
R21 · FY2019 · CA · contact PI
Cell specific blockade of PGE2 formation in the colon$81,625
R03 · FY2019 · CA · contact PI
(PQ11) Dietary strategies to enhance FOLFOX cancer therapies$189,744
R21 · FY2018 · CA · contact PI
Are ACF Surrogate Markers for Chemoprevention?$382,490
R01 · FY2016 · CA · contact PI
Are ACF Surrogate Markers for Chemoprevention?$443,639
R01 · FY2015 · CA · contact PI
Are ACF Surrogate Markers for Chemoprevention?$378,520
R01 · FY2014 · CA · contact PI
Are ACF Surrogate Markers for Chemoprevention?$356,279
R01 · FY2013 · CA · contact PI
Using Mouse Endoscopy for Evaluating Colon Cancer$350,125
R01 · FY2012 · CA · contact PI
Are ACF Surrogate Markers for Chemoprevention?$333,362
R01 · FY2012 · CA · contact PI
Using Mouse Endoscopy for Evaluating Colon Cancer$351,459
R01 · FY2011 · CA · contact PI
Using Mouse Endoscopy for Evaluating Colon Cancer$362,967
R01 · FY2010 · CA · contact PI
Altered Arachidonic Acid Balance and Colon Cancer$325,756
R01 · FY2010 · CA · contact PI
Using Mouse Endoscopy for Evaluating Colon Cancer$340,525
R01 · FY2009 · CA · contact PI
Altered Arachidonic Acid Balance and Colon Cancer$320,051
R01 · FY2009 · CA · contact PI
Using Mouse Endoscopy for Evaluating Colon Cancer$354,513
R01 · FY2008 · CA · contact PI
Altered Arachidonic Acid Balance and Colon Cancer$311,403
R01 · FY2008 · CA · contact PI
Molecular Characterization of ACF (Abberant Crypt Foci)$243,043
R01 · FY2008 · CA · contact PI
Altered Arachidonic Acid Balance and Colon Cancer$305,945
R01 · FY2007 · CA · contact PI
Molecular Characterization of ACF (Abberant Crypt Foci)$243,043
R01 · FY2007 · CA · contact PI
Altered Arachidonic Acid Balance and Colon Cancer$318,622
R01 · FY2006 · CA · contact PI
Molecular Characterization of ACF (Abberant Crypt Foci)$252,186
R01 · FY2006 · CA · contact PI
Molecular Characterization of ACF (Abberant Crypt Foci)$275,500
R01 · FY2005 · CA
Molecular Characterization of ACF (Abberant Crypt Foci)$261,000
R01 · FY2004 · CA
Gene Expression Profile in Patients with Hypersensitivi$573
M01 · FY2004 · RR
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI)$235,811
R01 · FY2002 · CA
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI)$234,228
R01 · FY2001 · CA
MOLECULAR CHARACTERIZATION OF ACF (ABERRANT CRYPT FOCI)$215,309
R01 · FY2001 · CA
Effects of oxidant balance on colon and breast cancer$146,144
P20 · FY2001 · CA
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION$71,001
R03 · FY2001 · ES
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION$54,143
R03 · FY2000 · ES
MECHANISMS OF INTESTINAL CARCINOGENESIS OF DISINFECTION$16,690
R03 · FY2000 · ES